Therefore, to explore the roles of FPR2 in cortical lesions of FCDIIb and TSC patients, we examined the expression and cellular distribution of FPR2 and its endogenous ligand RvD1 and the downstream NF‐κB signaling pathway. This evidence concerns the gene FPR2 and tuberous sclerosis.